[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid

C29H25ClN10O5 — CID 66698447

IUPAC[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
SMILESO=C(O)Nc1ccc(-c2cc(C(Cc3cc4n(n3)CCCO4)NC(=O)C=Cc3cc(Cl)ccc3-n3cnnn3)n[nH]c2=O)cc1
InChIInChI=1S/C29H25ClN10O5/c30-19-5-8-25(40-16-31-37-38-40)18(12-19)4-9-26(41)33-23(13-21-14-27-39(36-21)10-1-11-45-27)24-15-22(28(42)35-34-24)17-2-6-20(7-3-17)32-29(43)44/h2-9,12,14-16,23,32H,1,10-11,13H2,(H,33,41)(H,35,42)(H,43,44)
InChIKeyZSYNBVWXPWGAJA-UHFFFAOYSA-N
MW629.04 g/mol
LogP3.25
Rot. Bonds9

About [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid

[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid (PubChem CID 66698447) has the molecular formula C29H25ClN10O5 and a molecular weight of 629.04 g/mol. Its IUPAC name is [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid.

Molecular Properties

Compound Name[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
PubChem CID66698447
Molecular FormulaC29H25ClN10O5
Molecular Weight629.04 g/mol
Exact Mass628.17
IUPAC Name[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
SMILESO=C(O)Nc1ccc(-c2cc(C(Cc3cc4n(n3)CCCO4)NC(=O)C=Cc3cc(Cl)ccc3-n3cnnn3)n[nH]c2=O)cc1
InChIInChI=1S/C29H25ClN10O5/c30-19-5-8-25(40-16-31-37-38-40)18(12-19)4-9-26(41)33-23(13-21-14-27-39(36-21)10-1-11-45-27)24-15-22(28(42)35-34-24)17-2-6-20(7-3-17)32-29(43)44/h2-9,12,14-16,23,32H,1,10-11,13H2,(H,33,41)(H,35,42)(H,43,44)
InChIKeyZSYNBVWXPWGAJA-UHFFFAOYSA-N
XLogP3.25
TPSA194.83 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms45
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500629.04
LogP ≤ 53.25
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The IUPAC name of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid (CID 66698447) is [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid.
What is the SMILES notation for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The canonical SMILES for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid is O=C(O)Nc1ccc(-c2cc(C(Cc3cc4n(n3)CCCO4)NC(=O)C=Cc3cc(Cl)ccc3-n3cnnn3)n[nH]c2=O)cc1.
What is the InChIKey of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The InChIKey is ZSYNBVWXPWGAJA-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H25ClN10O5/c30-19-5-8-25(40-16-31-37-38-40)18(12-19)4-9-26(41)33-23(13-21-14-27-39(36-21)10-1-11-45-27)24-15-22(28(42)35-34-24)17-2-6-20(7-3-17)32-29(43)44/h2-9,12,14-16,23,32H,1,10-11,13H2,(H,33,41)(H,35,42)(H,43,44).
What are the key properties of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid has a molecular weight of 629.04 g/mol, XLogP of 3.25, 9 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid is sourced from PubChem (CID 66698447), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).